FOLFIRINOX Versus Gemcitabine/Nab-Paclitaxel for Neoadjuvant Treatment of Resectable and Borderline Resectable Pancreatic Head Adenocarcinoma
Dhir, Mashaal, Zenati, Mazen S., Hamad, Ahmad, Singhi, Aatur D., Bahary, Nathan, Hogg, Melissa E., Zeh, Herbert J., Zureikat, Amer H.Volume:
25
Language:
english
Journal:
Annals of Surgical Oncology
DOI:
10.1245/s10434-018-6512-8
Date:
July, 2018
File:
PDF, 453 KB
english, 2018